Deville les Rouen, France

Guillaume Levilain

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Deville les Rouen, FR (2013 - 2014)
  • Deville des Rouen, FR (2021 - 2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Guillaume Levilain

Introduction

Guillaume Levilain is a notable inventor based in Deville les Rouen, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on crystalline phases of specific compounds. With a total of 5 patents to his name, Levilain's inventions have the potential to impact medical therapy positively.

Latest Patents

Among his latest patents, Levilain has developed novel crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole, commonly known as Maribavir. This invention relates to pharmaceutical compositions that utilize these crystalline phases and their applications in medical therapy. His work in this area demonstrates a commitment to advancing pharmaceutical science and improving therapeutic options for patients.

Career Highlights

Throughout his career, Guillaume Levilain has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Takeda Pharmaceutical Company Limited and Viropharma Incorporated. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities in the field.

Collaborations

Levilain has collaborated with esteemed colleagues, including Gerard Coquerel and Marie-Noelle Petit. These partnerships have likely fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

In summary, Guillaume Levilain is a distinguished inventor whose work in pharmaceutical innovations has the potential to enhance medical therapies. His contributions, particularly in the area of crystalline phases, reflect a dedication to improving health outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…